NCT02221271View on ClinicalTrials.gov

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Guillain-Barré Syndrome
Interventions
DRUG

NPB-01

Trial Locations (1)

Unknown

Nihon Pharmaceutical Co., Ltd, Osaka

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY